Misoprostol for intrauterine fetal death
- PMID: 17961568
- DOI: 10.1016/j.ijgo.2007.09.010
Misoprostol for intrauterine fetal death
Abstract
The frequency of intrauterine fetal death (IUFD) with retained fetus varies, but is estimated to occur in 1% of all pregnancies. The vast majority of women will spontaneously labor and deliver within three weeks of the intrauterine death. The complexity in medical management increases significantly when the cervix is unripe or unfavorable, or when the woman develops disseminated intravascular coagulation. Misoprostol regimens for the induction of labor for second and third trimester IUFDs, range from 50 to 400 microg every 3 to 12 h, and are all clinically effective. Nevertheless, the current scientific evidence supports vaginal misoprostol dosages, which are adjusted to gestational age: between 13-17 weeks, 200 microg 6-hourly; between 18-26 weeks, 100 microg 6-hourly; and more than 27 weeks, 25-50 microg 4-hourly. In women with a previous cesarean, lower doses should be used and doubling of doses should not occur. Clinical monitoring should continue after delivery or expulsion because of the risk of postpartum atony and/or placenta retention.
Similar articles
-
Misoprostol to treat missed abortion in the first trimester.Int J Gynaecol Obstet. 2007 Dec;99 Suppl 2:S182-5. doi: 10.1016/j.ijgo.2007.09.008. Epub 2007 Oct 24. Int J Gynaecol Obstet. 2007. PMID: 17961567
-
Vaginal misoprostol versus intravenous oxytocin for the management of second-trimester pregnancies with intrauterine fetal death: A randomized clinical trial.J Obstet Gynaecol Res. 2016 Mar;42(3):246-51. doi: 10.1111/jog.12910. Epub 2015 Dec 10. J Obstet Gynaecol Res. 2016. PMID: 26663590 Clinical Trial.
-
Low-dose vaginal misoprostol in the management of intrauterine fetal death.J Matern Fetal Neonatal Med. 2011 Oct;24(10):1239-42. doi: 10.3109/14767058.2011.561386. Epub 2011 Jun 30. J Matern Fetal Neonatal Med. 2011. PMID: 21714693
-
Interruption of nonviable pregnancies of 24-28 weeks' gestation using medical methods: release date June 2013 SFP guideline #20133.Contraception. 2013 Sep;88(3):341-9. doi: 10.1016/j.contraception.2013.05.001. Epub 2013 May 9. Contraception. 2013. PMID: 23756114 Review.
-
Misoprostol for the termination of pregnancy with a live fetus at 13 to 26 weeks.Int J Gynaecol Obstet. 2007 Dec;99 Suppl 2:S178-81. doi: 10.1016/j.ijgo.2007.09.007. Epub 2007 Oct 24. Int J Gynaecol Obstet. 2007. PMID: 17961566 Review.
Cited by
-
Misoprostol-augmented induction of labour for third trimester fetal demise in a patient with prior hysterotomies.BMJ Case Rep. 2021 Jan 29;14(1):e239872. doi: 10.1136/bcr-2020-239872. BMJ Case Rep. 2021. PMID: 33514616 Free PMC article.
-
Retrospective Cohort Study of Lassa Fever in Pregnancy, Southern Nigeria.Emerg Infect Dis. 2019 Aug;25(8):1494-500. doi: 10.3201/eid2508.181299. Emerg Infect Dis. 2019. PMID: 31310586 Free PMC article.
-
Effectiveness and safety of sublingual misoprostol in medical treatment of the 1st trimester miscarriage: experience of off-label use in Korea.Obstet Gynecol Sci. 2018 Mar;61(2):220-226. doi: 10.5468/ogs.2018.61.2.220. Epub 2018 Mar 2. Obstet Gynecol Sci. 2018. PMID: 29564312 Free PMC article.
-
Route of Delivery in Women With Stillbirth: Results From the Stillbirth Collaborative Research Network.Obstet Gynecol. 2017 Apr;129(4):693-698. doi: 10.1097/AOG.0000000000001935. Obstet Gynecol. 2017. PMID: 28333794 Free PMC article.
-
Off-label use of misoprostol in gynaecology.Facts Views Vis Obgyn. 2015 Dec 28;7(4):261-264. Facts Views Vis Obgyn. 2015. PMID: 27729972 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical